Details

Last Funding Type

Series B

Last Funding Money Raised

$43.20M

Industries

Biopharma,Biotechnology,Health Care,Therapeutics

Founded date

Jan 1, 2016

Number Of Employee

1 - 10

Operating Status

Active

Bionaut Labs revolutionizes the treatment of central nervous system disorders with its precision medicine treatment modality. By creating a new medical modality of remote-controlled micro-robots called Bionauts, the company can transform the way the biopharmaceutical industry develops treatments, allowing them to engineer the therapeutic index for efficacy and maintain safety.

Bionaut Labs is focused on helping patients suffering from debilitating brain diseases who have few available treatment options. The anatomical targeting capabilities of the Bionaut platform make new therapeutics technologies such as gene therapy, CRISPR-Cas9, and oncolytic viruses viable in challenging clinical settings.